Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The goal of this clinical trial is to learn if a digital web application can prevent the risks related to cannabis use among adult regular cannabis users who are enrolled in a pilot trial for cannabis sales regulation conducted in Lausanne, Switzerland (i.e., Cann-L study) and have agreed that their data were used in other studies.
The main question it aims to answer is:
Do participants who have access to the intervention modules of the web application raise their use of protective behavioral strategies to lower cannabis-related risks?
Researchers will compare the intervention modules to a control module (i.e., information on cannabis-related risks and harm reduction) to see if the web application works to prevent the risks related to cannabis use. They will also compare intervention modules across each other to see whether one works better than another.
Participants will:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Inclusion criteria in Cann-L study are:
Exclusion criteria
The consent to participate in the Cann-L parent trial comprises an option to be contacted to participate in sub-studies, including studies on prevention measures. All participants having accepted to be so contacted will be proposed to participate in the present study.
Therefore, additional exclusion criteria for the present study include:
Primary purpose
Allocation
Interventional model
Masking
565 participants in 5 patient groups
Loading...
Central trial contact
Jacques Gaume, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal